STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and moreWorldPing
Image via STAT.

What happened

Vaxcyte said its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a competition with Pfizer and Merck…

Key facts

  • Vaxcyte said its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a competition with Pfizer and Merck…
  • Reported by STAT and published Mon, 05 Oct 2026 13:10:03 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. STAT+: Hospital and pharmaceutical prices are smothering America’s businesses

  2. Republicans and Democrats find a unifying target: Pharmacy benefit managers

  3. STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market

  4. STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage

Deutsche Welle
WorldPing
Deutsche Welle

Suspected pneumonic plague in Siberia: What we know about the disease

A worker at a plague research institute in Siberia has died, and nearly 200 of her contacts are under medical observation. Russian authorities deny a link to the bacterial infection. The US is monitoring the situation.

Brief by WorldPing · Original reporting by Deutsche Welle